Cargando…
Treatment of human hepatocellular carcinoma by the oncolytic herpes simplex virus G47delta
BACKGROUND: Oncolytic herpes simplex virus (HSV) can replicate in and kill cancer cells while sparing the adjacent normal tissue. Hepatocellular carcinoma (HCC) is amongst the most common and lethal cancers, especially in Third World countries. In this study, the cytotoxicity of a third-generation o...
Autores principales: | Wang, Jiani, Xu, Lihua, Zeng, Weigen, Hu, Pan, Zeng, Musheng, Rabkin, Samuel D, Liu, Renbin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4213511/ https://www.ncbi.nlm.nih.gov/pubmed/25360068 http://dx.doi.org/10.1186/s12935-014-0083-y |
Ejemplares similares
-
Anti-tumor effect of oncolytic herpes simplex virus G47delta on human nasopharyngeal carcinoma
por: Wang, Jia-Ni, et al.
Publicado: (2011) -
Treatment of breast cancer stem cells with oncolytic herpes simplex virus
por: Li, J, et al.
Publicado: (2012) -
Oncolytic herpes simplex viruses for the treatment of glioma and targeting glioblastoma stem-like cells
por: Kardani, Kimia, et al.
Publicado: (2023) -
Designing herpes viruses as oncolytics
por: Peters, Cole, et al.
Publicado: (2015) -
Oncolytic herpes simplex virus and immunotherapy
por: Ma, Wenqing, et al.
Publicado: (2018)